RVAC Medicines is a mRNA platform company engaged in the research and development of innovative products such as vaccines for diseases.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Apr 26, 2022 | Series B | $140M | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Pavilion Capital | — | Series B |